Norwegian Study Supports the Lowe Thesis.

[Guest guest]

Norwegian Study by Bjorn Johan Overbye, MD

Supports the " Lowe Thesis. "

Dr. C. Lowe

In the November 30th issues of Thyroid Science, Norwegian

physician/researcher Bjørn Johan Overbye, MD reported the results of his

year-long study of what he calls " the Lowe Thesis. " [1] The Lowe thesis is

one most readers of drlowe.com are familiar with. It states, that most

patients’ fibromyalgia results mainly from too little thyroid hormone

regulation, due either to hypothyroidism and/or peripheral thyroid hormone

resistance.

http://www.thyroidscience.com/experimental.studies/abstracts/Overbye.metabol

icfailure.fibromyalgia.htm

Dr. Overbye’s test result support my long-held hypothesis that has largely

been ignored by old guard researchers in the field of fibromyalgia. It often

happens in good medical science that the objective testing of a credible

hypothesis turned up new hypotheses that warrant careful note and future

study. This is true of Dr. Øverbye’s study; it potentially stokes the flames

of fibromyalgia research.

Almost simultaneously in the early 1990s, Professor J.B. Eisinger in France

and I in the USA proposed that metabolic impairment was the main cause of

fibromyalgia.[2][3] In a 1998 editorial in the Clinical Bulletin of

Myofascial Therapy, I wrote, " Eisinger’s work . . . deserves the focused

attention of all researchers and clinicians in the field. It should be clear

to anyone who has scrutinized fibromyalgia patients that they suffer from

metabolic impairment. In good science, such self-evident concepts serve as

the postulates upon which forward-moving studies are based. " Dr. Overbye’s

study is indeed one of those forward-moving studies in the field of

fibromyalgia.

The Øverbye study stands out as a high-quality mix of experimental and

theoretical work. As such, it contributes to the growth of today’s only

scientifically and logically plausible hypothesis of the cause of

fibromyalgia. The most important evidence he presents was derived from his

use of the long-respected Van method (first developed for the field

of hydrology and later adapted to medicine). His evidence confirms rather

than confutes the thesis.

More importantly, Dr. Overbye’s study is of great value to fibromyalgia

patients. In providing evidential support for the metabolic paradigm of

fibromyalgia, his study may influence more physicians to abandon the failed

therapies of the collapsed rheumatology paradigm of fibromyalgia[5,pp.57-91]

and give their patients proper metabolic therapy.

Dr. Overbye’s paper is technical. But I strongly recommend that readers

allow him to carry them through the subatomic world of energetics that is

the very foundation of the metabolic approach to fibromyalgia. I sincerely

thank Dr. Overbye for his unique contribution to the field and encourage him

to carry on his important experimental and theoretical work. Dr. Overbye's

Study